198 related articles for article (PubMed ID: 19841860)
1. Serum homocysteine, folate and vitamin B12 in patients with Paget's disease of bone: the effect of zoledronic acid.
Polyzos SA; Anastasilakis AD; Efstathiadou Z; Litsas I; Kita M; Panagiotou A; Papatheodorou A; Arsos G; Moralidis E; Barmpalios G; Zafeiriadou E; Triantafillidou E; Makrigiannaki E; Terpos E
J Bone Miner Metab; 2010 May; 28(3):314-9. PubMed ID: 19841860
[TBL] [Abstract][Full Text] [Related]
2. Relationship between bone mineral density, bone turnover markers and homocysteine, folate and vitamin B12 levels in postmenopausal women.
Haliloglu B; Aksungar FB; Ilter E; Peker H; Akin FT; Mutlu N; Ozekici U
Arch Gynecol Obstet; 2010 Apr; 281(4):663-8. PubMed ID: 19946695
[TBL] [Abstract][Full Text] [Related]
3. THE CLINICAL CHARACTERISTICS AND EFFICACY OF BISPHOSPHONATES IN AUDLT PATIENTS WITH OSTEOGENESIS IMPERGECTA.
Xu XJ; Ma DD; Lv F; Wang JY; Liu Y; Xia WB; Jiang Y; Wang O; Xing XP; Yu W; Li M
Endocr Pract; 2016 Nov; 22(11):1267-1276. PubMed ID: 27482615
[TBL] [Abstract][Full Text] [Related]
4. The effect of zoledronic acid on serum dickkopf-1, osteoprotegerin, and RANKL in patients with Paget's disease of bone.
Polyzos SA; Anastasilakis AD; Efstathiadou Z; Kita M; Litsas I; Avramidis A; Arsos G; Moralidis E; Gerou S; Pavlidou V; Papatheodorou A; Terpos E
Horm Metab Res; 2009 Nov; 41(11):846-50. PubMed ID: 19670154
[TBL] [Abstract][Full Text] [Related]
5. Dual-energy X-ray absorptiometry and quantitative ultrasound in patients with Paget's disease of bone before and after treatment with zoledronic acid: association with serum bone markers and Dickkopf-1.
Polyzos SA; Anastasilakis AD; Litsas I; Sapranidis M; Efstathiadou Z; Kita M; Arsos G; Moralidis E; Zafeiriadou E; Papatheodorou A; Terpos E
J Clin Densitom; 2010; 13(2):190-6. PubMed ID: 20347367
[TBL] [Abstract][Full Text] [Related]
6. Changes in bone resorption and vascular endothelial growth factor after a single zoledronic acid infusion in cancer patients with bone metastases from solid tumours.
Santini D; Vincenzi B; Hannon RA; Brown JE; Dicuonzo G; Angeletti S; La Cesa A; Coleman RE; Tonini G; Budillon A; Caraglia M; Holen I
Oncol Rep; 2006 May; 15(5):1351-7. PubMed ID: 16596210
[TBL] [Abstract][Full Text] [Related]
7. Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate.
McClung M; Recker R; Miller P; Fiske D; Minkoff J; Kriegman A; Zhou W; Adera M; Davis J
Bone; 2007 Jul; 41(1):122-8. PubMed ID: 17468062
[TBL] [Abstract][Full Text] [Related]
8. Denosumab in treatment-naïve and pre-treated with zoledronic acid postmenopausal women with low bone mass: Effect on bone mineral density and bone turnover markers.
Anastasilakis AD; Polyzos SA; Efstathiadou ZA; Savvidis M; Sakellariou GT; Papatheodorou A; Kokkoris P; Makras P
Metabolism; 2015 Oct; 64(10):1291-7. PubMed ID: 26198440
[TBL] [Abstract][Full Text] [Related]
9. Folate supplementation does not affect biochemical markers of bone turnover.
Herrmann M; Stanger O; Paulweber B; Hufnagl C; Herrmann W
Clin Lab; 2006; 52(3-4):131-6. PubMed ID: 16584059
[TBL] [Abstract][Full Text] [Related]
10. Zoledronic acid and survival in patients with metastatic bone disease from lung cancer and elevated markers of osteoclast activity.
Hirsh V; Major PP; Lipton A; Cook RJ; Langer CJ; Smith MR; Brown JE; Coleman RE
J Thorac Oncol; 2008 Mar; 3(3):228-36. PubMed ID: 18317064
[TBL] [Abstract][Full Text] [Related]
11. Folate, vitamin B12 and Homocysteine status in the post-folic acid fortification era in different subgroups of the Brazilian population attended to at a public health care center.
Barnabé A; Aléssio AC; Bittar LF; de Moraes Mazetto B; Bicudo AM; de Paula EV; Höehr NF; Annichino-Bizzacchi JM
Nutr J; 2015 Feb; 14():19. PubMed ID: 25886278
[TBL] [Abstract][Full Text] [Related]
12. Comparative effect of zoledronic acid versus denosumab on serum sclerostin and dickkopf-1 levels of naive postmenopausal women with low bone mass: a randomized, head-to-head clinical trial.
Anastasilakis AD; Polyzos SA; Gkiomisi A; Bisbinas I; Gerou S; Makras P
J Clin Endocrinol Metab; 2013 Aug; 98(8):3206-12. PubMed ID: 23788684
[TBL] [Abstract][Full Text] [Related]
13. Effects of intravenous zoledronic acid and oral ibandronate on early changes in markers of bone turnover in patients with bone metastases from non-small cell lung cancer.
Francini F; Pascucci A; Bargagli G; Francini E; Conca R; Miano ST; Martellucci I; Migali C; Gotti G; Fiaschi AI; Cozzolino A; Petrioli R
Int J Clin Oncol; 2011 Jun; 16(3):264-9. PubMed ID: 21240683
[TBL] [Abstract][Full Text] [Related]
14. Serum homocysteine, folate, vitamin B12 levels and arterial stiffness in diabetic patients: which of them is really important in atherogenesis?
Shargorodsky M; Boaz M; Pasternak S; Hanah R; Matas Z; Fux A; Beigel Y; Mashavi M
Diabetes Metab Res Rev; 2009 Jan; 25(1):70-5. PubMed ID: 19065546
[TBL] [Abstract][Full Text] [Related]
15. Biochemical markers of bone turnover and clinical outcome in patients with renal cell and bladder carcinoma with bone metastases following treatment with zoledronic acid: The TUGAMO study.
Alcaraz A; González-López R; Morote J; de la Piedra C; Meseguer C; Esteban E; Climent M; González-Gragera B; Alvarez-Ossorio JL; Chirivella I; Mellado B; Lara PC; Vázquez F; Contreras JA; Carles J; Murias A; Calderero V; Comet-Batlle J; González-Del Alba A; León-Mateos L; Mañas A; Segarra J; Lassa A; González-Enguita C; Méndez MJ; Samper P; Unda M; Mahillo-Fernández I; Bellmunt J;
Br J Cancer; 2013 Jul; 109(1):121-30. PubMed ID: 23799855
[TBL] [Abstract][Full Text] [Related]
16. Additive effects of zoledronic acid and propranolol on bone density and biochemical markers of bone turnover in osteopenic ovariectomized rats.
Khajuria DK; Razdan R; Mahapatra DR
Rev Bras Reumatol; 2015; 55(2):103-12. PubMed ID: 25582996
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of Homocysteine, Vitamin B12 and Folate in Patients with Multiple Sclerosis: an Updated Meta-Analysis.
Li X; Yuan J; Han J; Hu W
Int J Med Sci; 2020; 17(6):751-761. PubMed ID: 32218697
[No Abstract] [Full Text] [Related]
18. Plasma Homocysteine and Serum Folate and Vitamin B
Ma F; Wu T; Zhao J; Ji L; Song A; Zhang M; Huang G
Nutrients; 2017 Jul; 9(7):. PubMed ID: 28698453
[TBL] [Abstract][Full Text] [Related]
19. Zoledronic acid acutely increases sclerostin serum levels in women with postmenopausal osteoporosis.
Catalano A; Morabito N; Basile G; Brancatelli S; Cucinotta D; Lasco A
J Clin Endocrinol Metab; 2013 May; 98(5):1911-5. PubMed ID: 23596142
[TBL] [Abstract][Full Text] [Related]
20. Intravenous Zoledronic Acid 5 mg on Bone Turnover Markers and Bone Mineral Density in East China Subjects with Newly Diagnosed Osteoporosis: A 24-month Clinical Study.
Liang BC; Shi ZY; Wang B; Wu P; Kong LC; Yao JL; Li CW; Shi XL
Orthop Surg; 2017 Feb; 9(1):103-109. PubMed ID: 28276638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]